'Alternative smoking products ban could ensure health'
Henry Tong says the proposal to ban alternative smoking products is crucial in ensuring public health. File photo: RTHK
The chairman of the Hong Kong Council on Smoking and Health on Friday welcomed the government's proposed anti-smoking measures, including barring alternative smoking products.
Henry Tong told RTHK that the ban is crucial in ensuring the health of the public, particularly young people.
"There has been research showing that for young smokers who use e-cigarettes, there is a much higher chance that they become lifetime smokers," he said.
"Because most smokers who get cancer or heart disease or strokes, I think over 95 percent of them, they were treated by the Hong Kong public health system, which adds a lot of pressure to our public health system," Tong added.
The administration is looking to impose stiffer penalties for those who bring in more than the permitted amount of 19 sticks of undeclared cigarettes.
Offenders would be fined HK$5,000 instead of the current HK$2,000.
The measure would take effect immediately once the amendment bill is gazetted.
At the same time, those bringing in illicit cigarettes would be fined HK$2 million – double the current amount, and face a jail term that is five years more than the current seven.
Tong said he believes these proposed measures could reduce the number of illicit cigarettes.
As for the proposal to have all cigarette packages uniformly designed, he said it would discourage smokers who have quit from picking up the habit again.
"Even sometimes when they have a low intention to smoke, they were attracted to trying cigarettes because if you go to a convenience store, or go to a newspaper stand in Hong Kong, right now, in most cases, the cigarette packs are nicely arranged according to their brand name, and sometimes, even some kind of promotional wording on the pack facing the customer arranged in a nice light box."
Tong added similar measures are being enforced in other places.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
RTHK
a day ago
- RTHK
HK, Macau & Guangdong in joint anti-mosquito campaign
HK, Macau & Guangdong in joint anti-mosquito campaign The Centre for Health Protection said it will take appropriate preventive and control measures to prevent the spread of Chikungunya fever in Hong Kong. File photo: RTHK The Centre for Health Protection (CHP) on Tuesday said it is working closely with health authorities in Macau and Guangdong to fight the spread of Chikungunya fever. According to the World Health Organization, more than 220,000 cases had been recorded in 14 countries and regions, including about 80 fatal ones, as of early June. The Foshan Municipal Health Bureau announced that, as of last Sunday, there had been 2,285 confirmed cases there. Most cases were found in Shunde District. All cases were mild. The controller of the CHP, Edwin Tsui, said the SAR stayed informed with the latest development of the mosquito-borne disease in Guangdong province. Macau, meanwhile, recorded its first case of Chikungunya fever on Friday. It was classified as an imported case. 'Although no confirmed Chikungunya fever cases have been recorded in Hong Kong so far this year, higher temperatures and rainfall in summer are expected to aggravate mosquito infestation in Hong Kong. Additionally, people travel more frequently during the summer holidays, including to regions where mosquito-borne diseases are endemic," Tsui said. 'Consequently, there is an increased risk of imported cases and local transmission of mosquito-borne diseases, such as Chikungunya fever and dengue fever. Members of the public are advised to take protection measures against mosquitoes, whether they're here or travelling outside of Hong Kong." Tsui said inspections have been stepped up at border control points to ensure good environmental hygiene, and temperature checks are conducted for inbound travellers. Travellers with fever will be referred to hospitals when necessary. The CHP will also provide the latest disease information and health advice to the tourism sector and airlines. The centre has issued a letter to all doctors and hospitals in Hong Kong to provide them with the latest epidemiological information. Doctors are urged to watch out for Chikungunya fever-related symptoms among people who return to Hong Kong from outbound travel, and to report cases to the Department of Health. An interdepartmental steering committee will hold a meeting on Wednesday to review the latest situation and anti-mosquito work of various departments.
HKFP
3 days ago
- HKFP
Hong Kong's Hospital Authority negotiates lower prices for medication as part of cost-cutting measures
Hong Kong's Hospital Authority has negotiated lower prices for medication following discussions with pharmaceutical firms, as part of cost-cutting measures aimed at optimising resources. Hospital Authority chief executive Tony Ko said on Wednesday that, of the pharmaceutical firms it had spoken with – most of which make drugs for cancer and chronic conditions – around 70 per cent agreed to lower prices. The average price cut was about 20 per cent. The Hospital Authority is also planning to rely more on generic drugs instead of brand-name medication, Ko said, citing expiring patents on some drugs paving the way for other manufacturers. William Chui, the Hospital Authority's chief pharmacist, said that market competition could lower prices across the board. 'Whether it's generic drugs manufactured in India, Western countries or mainland China, the original manufacturers will follow by reducing their prices,' Chui said in Cantonese. Last year, the Hospital Authority established a 'Cost Assessment Panel' to negotiate costs with pharmaceutical firms. In March, the Health Bureau said it had reduced procurement costs for some drugs for colon cancer and paroxysmal nocturnal haemoglobinuria, a type of rare blood disorder. The Hospital Authority will continue to promote the 'diversification of drug supply so as to provide patients with safe, efficacious and cost-effective drugs,' the bureau added. On Wednesday, Chui said authorities had taken reference from drug prices offered under mainland China's medical insurance system while negotiating costs. The Hospital Authority is also looking to purchase medical equipment from mainland China, he said. Ko added on Wednesday that the Hospital Authority has been using artificial intelligence (AI) to draft medical reports since March. Around 80 per cent of reports can be processed by AI, he said, helping save about 40 per cent of the time staff spend handling paperwork. Lowered drug costs at public hospitals come as the city is set to raise fees for services such as non-critical Accident and Emergency (A&E) room visits. The hike is part of a reform that Secretary for Health Lo Chung-mau called 'belated and necessary,' saying that the current public healthcare system, which is heavily subsidised by the government, is not sustainable. Under the new plan, patients classified as 'urgent,' 'semi-urgent,' or 'non-urgent' will have to pay HK$400 for A&E services. The current fee has been HK$180 since 2017. Patients classified as 'critical,' referring to those who should receive immediate medical attention and those classified as 'emergency,' which should be attended to within 15 minutes, will be treated for free.
South China Morning Post
3 days ago
- South China Morning Post
CUHK start-ups eye silver economy's need for ‘wearable robotics'
A couple of health and medical device start-ups that got their start at the Chinese University of Hong Kong are seeking to enter the growing markets for elderly care and rehabilitation by selling their 'wearable robotics' technologies. Established last year, RT HealthTech has developed several soft inflatable joint support products. It plans to start selling them in two months, targeting elderly people with weaker joints and those with minor injuries who want to keep exercising to maintain muscle strength. They feature a rechargeable battery-powered mobile air-pumping system that can generate adjustable levels of force, said co-founder Raymond Tong Kai-yu in an interview earlier this month. 'The devices can keep knee and elbow joints in position, while providing an extra pair of 'artificial muscles' to reduce joint impact during physical activities,' said Tong, a professor and founding chairman of the university's Department of Biomedical Engineering. 'We are addressing the needs of the fast-growing silver economy.' The proportion of Hong Kong people aged 65 and over was projected to rise to 36 per cent in 2046 from 22.4 per cent in 2023, according to government projections. RT HealthTech was seeking to sell 1,000 units in the first three months at around HK$1,200 (US$153) each, Tong said. It planned to appoint a separate distributor for mainland China.
